source
- Undecimal Bio raises $18 million to expand siRNA platform beyond liver diseasesUndecimal Bio, founded by Yaniv Erlich and Shaul Ilan, announced a new financing round that brings in $18 million. The capital will support the company’s effort to develop siRNA therapeutics for ta…
- Japan's PMDA Issues Guidance to Safeguard Participants in Generic Bioequivalence TrialsThe Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has released new guidance aimed at protecting healthy adult volunteers who take part in generic bioequivalence studies. The document…